Advertisement

The Global Epidemiology of Diabetes and Kidney Disease

  • Digsu N. Koye
    Affiliations
    Department of Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ; and Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA
    Search for articles by this author
  • Dianna J. Magliano
    Affiliations
    Department of Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ; and Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA
    Search for articles by this author
  • Robert G. Nelson
    Affiliations
    Department of Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ; and Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA
    Search for articles by this author
  • Meda E. Pavkov
    Correspondence
    Address correspondence to Meda E. Pavkov, Centers for Disease Control and Prevention, 4770 Buford Highway, NE MS-F75, Atlanta, GA 30341-3724.
    Affiliations
    Department of Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; Chronic Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ; and Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA
    Search for articles by this author
      The prevalence of diabetes is increasing worldwide, with the greatest increases occurring in low- and middle-income countries. In most developed countries, type 2 diabetes is presently the leading cause of end-stage renal disease and also contributes substantially to cardiovascular disease. In countries with weaker economies type 2 diabetes is rapidly replacing communicable diseases as a leading cause of kidney disease and is increasingly competing for scarce health care resources. Here, we present a narrative review of the prevalence and incidence of diabetes-related kidney disease worldwide. Mortality among those with diabetes and kidney disease will also be explored. Given the high morbidity and mortality associated with chronic kidney disease, we will also examine the level of awareness of this disease among people who have it.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Chronic Kidney Disease
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Zimmet P.Z.
        • Magliano D.J.
        • Herman W.H.
        • Shaw J.E.
        Diabetes: a 21st century challenge.
        Lancet Diabetes Endocrinol. 2014; 2: 56-64
        • International Diabetes Federation
        IDF Diabetes Atlas.
        7th ed. International Diabetes Federation, Brussels, Belgium2015
        • Shaw J.E.
        • Sicree R.A.
        • Zimmet P.Z.
        Global estimates of the prevalence of diabetes for 2010 and 2030.
        Diabetes Res Clin Pract. 2010; 87: 4-14
        • NCD Risk Factor Collaboration (NCD-RisC)
        Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants.
        Lancet. 2016; 387: 1513-1530
        • Forouhi N.G.
        • Wareham N.J.
        Epidemiology of diabetes.
        Medicine (Abingdon). 2014; 42: 698-702
        • Minges K.E.
        • Zimmet P.
        • Magliano D.J.
        • Dunstan D.W.
        • Brown A.
        • Shaw J.E.
        Diabetes prevalence and determinants in Indigenous Australian populations: a systematic review.
        Diabetes Res Clin Pract. 2011; 93: 139-149
        • Atkinson M.A.
        • Eisenbarth G.S.
        • Michels A.W.
        Type 1 diabetes.
        Lancet (London, England). 2014; 383: 69-82
        • Maahs D.M.
        • West N.A.
        • Lawrence J.M.
        • Mayer-Davis E.J.
        Epidemiology of type 1 diabetes.
        Endocrinol Metab Clin North Am. 2010; 39: 481-497
        • Harjutsalo V.
        • Sund R.
        • Knip M.
        • Groop P.-H.
        Incidence of type 1 diabetes in Finland.
        JAMA. 2013; 310: 427-428
        • DIAMOND Project Group
        Incidence and trends of childhood type 1 diabetes worldwide 1990-1999.
        Diabet Med. 2006; 23: 857-866
        • American Diabetes Association
        Statistics About Diabetes. American Diabetes Association.
        (Available at:)
        • Mayer-Davis E.J.
        • Lawrence J.M.
        • Dabelea D.
        • et al.
        Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012.
        N Engl J Med. 2017; 376: 1419-1429
        • Geiss L.S.
        • Wang J.
        • Cheng Y.J.
        • et al.
        Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012.
        JAMA. 2014; 312: 1218-1226
        • Weng W.
        • Liang Y.
        • Kimball E.S.
        • et al.
        Decreasing incidence of type 2 diabetes mellitus in the United States, 2007–2012: epidemiologic findings from a large US claims database.
        Diabetes Res Clin Pract. 2016; 117: 111-118
        • Jansson S.P.O.
        • Andersson D.K.G.
        • Svärdsudd K.
        Prevalence and incidence rate of diabetes mellitus in a Swedish community during 30 years of follow-up.
        Diabetologia. 2007; 50: 703-710
        • Read S.H.
        • Kerssens J.J.
        • McAllister D.A.
        • et al.
        Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013.
        Diabetologia. 2016; 59: 2106-2113
        • Jiang Y.-D.
        • Chang C.-H.
        • Tai T.-Y.
        • Chen J.-F.
        • Chuang L.-M.
        Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database.
        J Formos Med Assoc. 2012; 111: 599-604
        • Tseng C.H.
        • Tseng C.P.
        • Chong C.K.
        • et al.
        Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort.
        Diabetologia. 2006; 49: 1755-1760
        • Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group
        KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.
        Kidney Int Suppl. 2013; 3: 1-150
        • Harjutsalo V.
        • Groop P.H.
        Epidemiology and risk factors for diabetic kidney disease.
        Adv Chronic Kidney Dis. 2014; 21: 260-266
        • Thomas M.C.
        • Brownlee M.
        • Susztak K.
        • et al.
        Diabetic kidney disease.
        Nat Rev Dis Primers. 2015; 1: 15018
        • Nelson R.G.
        • Morgenstem H.
        • Bennett P.H.
        Birth weight and renal disease in Pima Indians with type 2 diabetes mellitus.
        Am J Epidemiol. 1998; 148: 650-656
        • Shultis W.A.
        • Weil E.J.
        • Looker H.C.
        • et al.
        Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes.
        Diabetes Care. 2007; 30: 306-311
        • Thomas M.C.
        • Cooper M.E.
        • Zimmet P.
        Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.
        Nat Rev Nephrol. 2016; 12: 73-81
        • Weil E.J.
        • Curtis J.M.
        • Hanson R.L.
        • Knowler W.C.
        • Nelson R.G.
        The impact of disadvantage on the development and progression of diabetic kidney disease.
        Clin Nephrol. 2010; 74: S32-S38
        • Ene-Iordache B.
        • Perico N.
        • Bikbov B.
        • et al.
        Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.
        Lancet Glob Health. 2016; 4: e307-e319
        • Lu B.
        • Song X.
        • Dong X.
        • et al.
        High prevalence of chronic kidney disease in population-based patients diagnosed with type 2 diabetes in downtown Shanghai.
        J Diabet Complications. 2008; 22: 96-103
        • Jia W.
        • Gao X.
        • Pang C.
        • et al.
        Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS).
        Nephrol Dial Transplant. 2009; 24: 3724-3731
        • Collins A.J.
        • Vassalotti J.A.
        • Wang C.
        • et al.
        Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
        Am J Kidney Dis. 2009; 53: S71-S77
        • Plantinga L.C.
        • Crews D.C.
        • Coresh J.
        • et al.
        Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes.
        Clin J Am Soc Nephrol. 2010; 5: 673-682
        • Ohta M.
        • Babazono T.
        • Uchigata Y.
        • Iwamoto Y.
        Comparison of the prevalence of chronic kidney disease in Japanese patients with type 1 and type 2 diabetes.
        Diabet Med. 2010; 27: 1017-1023
        • Assogba G.F.
        • Couchoud C.
        • Roudier C.
        • et al.
        Prevalence, screening and treatment of chronic kidney disease in people with type 2 diabetes in France: the ENTRED surveys (2001 and 2007).
        Diabetes Metab. 2012; 38: 558-566
        • Coll-de-Tuero G.
        • Mata-Cases M.
        • Rodriguez-Poncelas A.
        • et al.
        Chronic kidney disease in the type 2 diabetic patients: prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area.
        BMC Nephrol. 2012; 13: 87
        • Zhou Y.
        • Echouffo-Tcheugui J.B.
        • Gu J.J.
        • et al.
        Prevalence of chronic kidney disease across levels of glycemia among adults in Pudong New Area, Shanghai, China.
        BMC Nephrol. 2013; 14: 253
        • Rodriguez-Poncelas A.
        • Garre-Olmo J.
        • Franch-Nadal J.
        • et al.
        Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study.
        BMC Nephrol. 2013; 14: 46
        • Janmohamed M.N.
        • Kalluvya S.E.
        • Mueller A.
        • et al.
        Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania.
        BMC Nephrol. 2013; 14: 183
        • Ahn J.H.
        • Yu J.H.
        • Ko S.-H.
        • et al.
        Prevalence and determinants of diabetic nephropathy in Korea: Korea national health and nutrition examination survey.
        Diabetes Metab J. 2014; 38: 109-119
        • Bailey R.A.
        • Wang Y.
        • Zhu V.
        • Rupnow M.F.
        Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging.
        BMC Res Notes. 2014; 7: 415
        • Metsarinne K.
        • Broijersen A.
        • Kantola I.
        • et al.
        High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
        Prim Care Diabetes. 2015; 9: 31-38
        • Low S.K.
        • Sum C.F.
        • Yeoh L.Y.
        • et al.
        Prevalence of chronic kidney disease in adults with type 2 diabetes mellitus.
        Ann Acad Med Singapore. 2015; 44: 164-171
        • Guo K.
        • Zhang L.
        • Zhao F.
        • et al.
        Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: cross-sectional study.
        J Diabet Complications. 2016; 30: 803-810
        • Laranjinha I.
        • Matias P.
        • Mateus S.
        • et al.
        Diabetic kidney disease: is there a non-albuminuric phenotype in type 2 diabetic patients?.
        Nefrologia. 2016; 36: 503-509
        • Chadban S.J.
        • Briganti E.M.
        • Kerr P.G.
        • et al.
        Prevalence of kidney damage in Australian adults: the AusDiab Kidney Study.
        J Am Soc Nephrol. 2003; 14: S131-S138
        • Afkarian M.
        • Zelnick L.R.
        • Hall Y.N.
        • et al.
        Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014.
        JAMA. 2016; 316: 602-610
        • Brück K.
        • Stel V.S.
        • Gambaro G.
        • et al.
        CKD prevalence varies across the European general population.
        J Am Soc Nephrol. 2016; 27: 2135-2147
        • Stanifer J.W.
        • Jing B.
        • Tolan S.
        • et al.
        The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis.
        Lancet Glob Health. 2014; 2: e174-e181
        • Noubiap J.J.N.
        • Naidoo J.
        • Kengne A.P.
        Diabetic nephropathy in Africa: a systematic review.
        World J Diabetes. 2015; 6: 759-773
        • Swanepoel C.R.
        • Wearne N.
        • Okpechi I.G.
        Nephrology in Africa—not yet uhuru.
        Nat Rev Nephrol. 2013; 9: 610-622
        • Sharif M.U.
        • Elsayed M.E.
        • Stack A.G.
        The global nephrology workforce: emerging threats and potential solutions!.
        Clin Kidney J. 2016; 9: 11-22
        • Grice B.A.
        • Nelson R.G.
        • Williams D.E.
        • et al.
        Associations between persistent organic pollutants, type 2 diabetes, diabetic nephropathy and mortality.
        Occup Environ Med. 2017; 74: 521-527
        • Glassock R.J.
        • Warnock D.G.
        • Delanaye P.
        The global burden of chronic kidney disease: estimates, variability and pitfalls.
        Nat Rev Nephrol. 2017; 13: 104-114
        • Pavkov M.E.
        • Mason C.C.
        • Bennett P.H.
        • Curtis J.M.
        • Knowler W.C.
        • Nelson R.G.
        Change in the distribution of albuminuria according to estimated glomerular filtration rate in Pima Indians with type 2 diabetes.
        Diabetes Care. 2009; 32: 1845-1850
        • Perkins B.A.
        • Ficociello L.H.
        • Silva K.H.
        • Finkelstein D.M.
        • Warram J.H.
        • Krolewski A.S.
        Regression of microalbuminuria in type 1 diabetes.
        N Engl J Med. 2003; 348: 2285-2293
        • Kramer H.J.
        • Nguyen Q.D.
        • Curhan G.
        • Hsu C.-Y.
        Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.
        JAMA. 2003; 289: 3273-3277
        • Thomas M.C.
        • Macisaac R.J.
        • Jerums G.
        • et al.
        Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11).
        Diabetes Care. 2009; 32: 1497-1502
        • MacIsaac R.J.
        • Tsalamandris C.
        • Panagiotopoulos S.
        • Smith T.J.
        • McNeil K.J.
        • Jerums G.
        Nonalbuminuric renal insufficiency in type 2 diabetes.
        Diabetes Care. 2004; 27: 195-200
        • Retnakaran R.
        • Cull C.A.
        • Thorne K.I.
        • Adler A.I.
        • Holman R.R.
        • Group U.S.
        Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.
        Diabetes. 2006; 55: 1832-1839
        • Molitch M.E.
        • Steffes M.
        • Sun W.
        • et al.
        Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.
        Diabetes Care. 2010; 33: 1536-1543
        • Dwyer J.P.
        • Parving H.-H.
        • Hunsicker L.G.
        • Ravid M.
        • Remuzzi G.
        • Lewis J.B.
        Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes: results from the DEMAND study.
        Cardiorenal Med. 2012; 2: 1-10
        • Parving H.H.
        • Lewis J.B.
        • Ravid M.
        • Remuzzi G.
        • Hunsicker L.G.
        • DEMAND investigators
        Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective.
        Kidney Int. 2006; 69: 2057-2063
        • Koye D.N.
        • Shaw J.E.
        • Reid C.M.
        • Atkins R.C.
        • Reutens A.T.
        • Magliano D.J.
        Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies.
        Diabet Med. 2017; 34: 887-901
        • Boer I.H.
        • Rue T.C.
        • Cleary P.A.
        • et al.
        Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort.
        Arch Intern Med. 2011; 171: 412-420
        • DCCT/EDIC research group
        Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
        Lancet Diabetes Endocrinol. 2014; 2: 793-800
        • Look A.R.G.
        Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial.
        Lancet Diabetes Endocrinol. 2014; 2: 801-809
        • Wakasugi M.
        • Kazama J.
        • Narita I.
        • et al.
        Association between overall lifestyle changes and the incidence of proteinuria: a population-based, cohort study.
        Intern Med. 2017; 56: 1475-1484
        • Adebamowo S.N.
        • Adeyemo A.A.
        • Tekola-Ayele F.
        • et al.
        Impact of type 2 diabetes on impaired kidney function in sub-Saharan African populations.
        Front Endocrinol (Lausanne). 2016; 7: 50
        • Chandie Shaw P.K.
        • Baboe F.
        • van Es L.A.
        • et al.
        South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients.
        Diabetes Care. 2006; 29: 1383-1385
        • Viswanathan V.
        • Tilak P.
        • Kumpatla S.
        Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study.
        Indian J Med Res. 2012; 136: 46-53
        • Hoerger T.J.
        • Simpson S.A.
        • Yarnoff B.O.
        • et al.
        The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative.
        Am J Kidney Dis. 2015; 65: 403-411
        • Hovind P.
        • Tarnow L.
        • Rossing K.
        • et al.
        Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.
        Diabetes Care. 2003; 26: 1258-1264
        • Krolewski A.S.
        • Warram J.H.
        • Christlieb A.R.
        • Busick E.J.
        • Kahn C.R.
        The changing natural history of nephropathy in type I diabetes.
        Am J Med. 1985; 78: 785-794
        • Pambianco G.
        • Costacou T.
        • Ellis D.
        • Becker D.J.
        • Klein R.
        • Orchard T.J.
        The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience.
        Diabetes. 2006; 55: 1463-1469
        • Rossing P.
        • Rossing K.
        • Jacobsen P.
        • Parving H.H.
        Unchanged incidence of diabetic nephropathy in IDDM patients.
        Diabetes. 1995; 44: 739-743
        • Bojestig M.
        • Arnqvist H.J.
        • Hermansson G.
        • Karlberg B.E.
        • Ludvigsson J.
        Declining incidence of nephropathy in insulin-dependent diabetes mellitus.
        N Engl J Med. 1994; 330: 15-18
        • Kofoed-Enevoldsen A.
        • Borch-Johnsen K.
        • Kreiner S.
        • Nerup J.
        • Deckert T.
        Declining incidence of persistent proteinuria in type I (insulin-dependent) diabetic patients in Denmark.
        Diabetes. 1987; 36: 205-209
        • Rossing P.
        The changing epidemiology of diabetic microangiopathy in type 1 diabetes.
        Diabetologia. 2005; 48: 1439-1444
        • Schroeder E.B.
        • Powers J.D.
        • O'Connor P.J.
        • et al.
        Prevalence of chronic kidney disease among individuals with diabetes in the SUPREME-DM Project, 2005-2011.
        J Diabetes Complications. 2015; 29: 637-643
        • United States Renal Data System
        2016 USRDS annual data report: epidemiology of kidney disease in the United States.
        National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD2016
        • Burrows N.R.
        • Li Y.
        • Geiss L.S.
        Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline.
        Diabetes Care. 2010; 33: 73-77
        • Gregg E.W.
        • Li Y.
        • Wang J.
        • et al.
        Changes in diabetes-related complications in the United States, 1990-2010.
        N Engl J Med. 2014; 370: 1514-1523
        • Murphy D.
        • McCulloch C.E.
        • Lin F.
        • et al.
        Trends in prevalence of chronic kidney disease in the United States.
        Ann Intern Med. 2016; 165: 473-481
        • Heaf J.G.
        • Wehberg S.
        Reduced incidence of end stage renal disease among the elderly in Denmark: an observational study.
        BMC Nephrol. 2012; 13: 131
        • Comas J.
        • Arcos E.
        • Castell C.
        • et al.
        Evolution of the incidence of chronic kidney disease Stage 5 requiring renal replacement therapy in the diabetic population of Catalonia.
        Nephrol Dial Transplant. 2013; 28: 1191-1198
        • White S.
        • Chadban S.
        Diabetic kidney disease in Australia: current burden and future projections.
        Nephrology (Carlton). 2014; 19: 450-458
        • Tancredi M.
        • Rosengren A.
        • Svensson A.-M.
        • et al.
        Excess mortality among persons with type 2 diabetes.
        N Engl J Med. 2015; 373: 1720-1732
        • Seshasai S.R.K.
        • Kaptoge S.
        • et al.
        • Emerging Risk Factors Collaboration
        Diabetes mellitus, fasting glucose, and risk of cause-specific death.
        N Engl J Med. 2011; 364: 829-841
        • Tonelli M.
        • Wiebe N.
        • Culleton B.
        • et al.
        Chronic kidney disease and mortality risk: a systematic review.
        J Am Soc Nephrol. 2006; 17: 2034-2047
        • Wen C.P.
        • Cheng T.Y.D.
        • Tsai M.K.
        • et al.
        All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan.
        Lancet (London, England). 2008; 371: 2173-2182
        • Svensson M.K.
        • Cederholm J.
        • Eliasson B.
        • Zethelius B.
        • Gudbjörnsdottir S.
        • Swedish National Diabetes R
        Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register.
        Diab Vasc Dis Res. 2013; 10: 520-529
        • Weiner D.E.
        • Tighiouart H.
        • Amin M.G.
        • et al.
        Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.
        J Am Soc Nephrol. 2004; 15: 1307-1315
        • Afkarian M.
        • Sachs M.C.
        • Kestenbaum B.
        • et al.
        Kidney disease and increased mortality risk in type 2 diabetes.
        J Am Soc Nephrol. 2013; 24: 302-308
        • Groop P.-H.
        • Thomas M.C.
        • Moran J.L.
        • et al.
        The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes.
        Diabetes. 2009; 58: 1651-1658
        • Orchard T.J.
        • Secrest A.M.
        • Miller R.G.
        • Costacou T.
        In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study.
        Diabetologia. 2010; 53: 2312-2319
        • Jager K.J.
        • Fraser S.D.S.
        The ascending rank of chronic kidney disease in the global burden of disease study.
        Nephrol Dial Transplant. 2017; 32: ii121-ii128
        • Centers for Disease Control and Prevention
        National Chronic Kidney Disease Fact Sheet, 2017.
        US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA2017
      1. 2017 USRDS Annual Data Report: Executive Summary. Chapter 2: Identification and Care of Patients With CKD.
        Am J Kidney Dis. 2018; 71: S31-S46
        • Sarnak M.J.
        • Levey A.S.
        • Schoolwerth A.C.
        • et al.
        Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention.
        Hypertension. 2003; 42: 1050-1065
        • Brown W.W.
        • Peters R.M.
        • Ohmit S.E.
        • et al.
        Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP).
        Am J Kidney Dis. 2003; 42: 22-35
        • Plantinga L.C.
        • Boulware L.E.
        • Coresh J.
        • et al.
        Patient awareness of chronic kidney disease: trends and predictors.
        Arch Intern Med. 2008; 168: 2268-2275
        • Saab G.
        • Whaley-Connell A.T.
        • McCullough P.A.
        • Bakris G.L.
        CKD awareness in the United States: the Kidney Early Evaluation Program (KEEP).
        Am J Kidney Dis. 2008; 52: 382-383
        • Nickolas T.L.
        • Frisch G.D.
        • Opotowsky A.R.
        • Arons R.
        • Radhakrishnan J.
        Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000.
        Am J Kidney Dis. 2004; 44: 185-197
        • Whaley-Connell A.
        • Bomback A.S.
        • McFarlane S.I.
        • et al.
        Diabetic cardiovascular disease predicts chronic kidney disease awareness in the Kidney Early Evaluation Program.
        Cardiorenal Med. 2011; 1: 45-52
        • Whaley-Connell A.
        • Sowers J.R.
        • McCullough P.A.
        • et al.
        Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
        Am J Kidney Dis. 2009; 53: S11-S21
        • Cirillo M.
        • Laurenzi M.
        • Mancini M.
        • Zanchetti A.
        • Lombardi C.
        • De Santo N.G.
        Low glomerular filtration in the population: prevalence, associated disorders, and awareness.
        Kidney Int. 2006; 70: 800-806
        • Jha V.
        • Garcia-Garcia G.
        • Iseki K.
        • et al.
        Chronic kidney disease: global dimension and perspectives.
        Lancet (London, England). 2013; 382: 260-272
        • Szczech L.A.
        • Stewart R.C.
        • Su H.-L.
        • et al.
        Primary care detection of chronic kidney disease in adults with type-2 diabetes: the ADD-CKD Study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease).
        PLoS ONE. 2014; 9: e110535
        • Verhave J.C.
        • Troyanov S.
        • Mongeau F.
        • et al.
        Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care.
        Clin J Am Soc Nephrol. 2014; 9: 713-719
        • Hemmelgarn B.R.
        • Manns B.J.
        • Lloyd A.
        • et al.
        Relation between kidney function, proteinuria, and adverse outcomes.
        JAMA. 2010; 303: 423-429